University of Toronto Mississauga spinout Janpix has obtained $17.6m in funding from corporate-backed Medicxi, which had seeded the company.

The surgical model developer, based on research at German Sport University College and University Hospital of Cologne, will use the cash to enter North American and Asian markets.

Avizia has acquired Carena, which counted McKesson, Cambia Health Solutions and Catholic Health Initiatives as investors, to form a diverse telehealth platform.

Bacterial infection treatment developer Spero Therapeutics has filed to raise up to $86.3m in an initial public offering that will enable a host of corporates to exit.

Allena Pharmaceuticals, a Pharmstandard-backed developer of metabolic and kidney disorder treatments, has filed to go public after raising $93m in venture capital.

ImaginAb, which has now raised approximately $4m in total, will continue development of the imaging agent it is developing for T-cell tumours.

The protective clothing developer has now raised more than $36m in total, after closing a round that included Northwell Ventures and Mercy Health.

The ophthalmology-focused drug developer, which is backed by pharmaceutical company Novo, plans to use the money to further test its lead product candidate.

Beta Bionics has been launched as a public benefit corporation to commercialise automated bihormonal pumps for type 1 diabetes sufferers.